NEW YORK (Reuters Health) – Rates of major adverse cardiovascular events (MACEs) are lower in hypertensive patients with coronary artery disease on amlodipine when candesartan is added to…
NEW YORK (Reuters Health) – Very elderly patients with ST-segment elevation MI can do quite well with successful primary percutaneous intervention, as long they aren’t in cardiogenic shock…
NEW YORK (Reuters Health) – When target cholesterol levels are not achieved with statin monotherapy in patients with mixed dyslipidemia, adding fenofibrate can tip the scales favorably. Dr.…
NEW YORK (Reuters Health) – Patients on warfarin need not discontinue treatment when they have a fecal occult blood test (FOBT), as it does not affect the predictive…
NEW YORK (Reuters Health) – Contrary to earlier concerns, the use of ultrasound contrast agents in echocardiography is not associated with an increased incidence of myocardial infarction or…
NEW YORK (Reuters Health) – Cardioversion of atrial fibrillation or flutter to sinus rhythm using ibutilide is more successful and less likely to trigger torsades de pointes when…
NEW YORK (Reuters Health) – Outcomes of percutaneous coronary intervention are just as good when a loading dose of clopidogrel is given in the cath lab just before…
NEW YORK (Reuters Health) – Stents coated with sirolimus (Cypher) and those coated with paclitaxel (Taxus) perform equally well for revascularization of saphenous vein grafts, investigators report. A…
NEW YORK (Reuters Health) – The safety and efficacy of intensive statin therapy initiated soon after a first MI are maintained at 5 years, Scandinavian investigators report. They…
NEW YORK (Reuters Health) – A lower INR for low-risk anticoagulated patients with mechanical aortic valve replacement reduces the risk of bleeding without increasing the rate of thromboembolic…